The BCR–ABL1 oncogene, which plays a critical role in chronic myeloid leukemia (CML), can stimulate β–catenin in the blast phase of CML [56]. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.